Bristol-Myers (BMY) Tops Q4 EPS by 5c; Issues In-Line FY13 EPS Outlook
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $57.13 +0.40%
EPS Growth %: +10.3%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +10.3%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $4.19 billion versus the consensus estimate of $4.14 billion.
Bristol-Myers Squibb Co. sees FY2013 EPS of $1.78-1.88, versus the consensus of $1.83.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Bristol-Myers Squibb Co. sees FY2013 EPS of $1.78-1.88, versus the consensus of $1.83.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
